D-0422-2025 Class II Terminated

Recalled by KENIL HEALTHCARE PRIVATE LIMITED — Ta. Kadi, District Mehsana, N/A

FDA drug recall D-0422-2025 was initiated by KENIL HEALTHCARE PRIVATE LIMITED on Apr 24, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Feb 19, 2026). Affected quantity: 10,128 Bottles.

Recall details

Product Type
Drugs
Report Date
May 28, 2025
Initiation Date
Apr 24, 2025
Termination Date
Feb 19, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,128 Bottles

Product description

CURA HONGOS, Antifungal, 1% Clotrimazole, Topical Lotion, 0.76 fl oz (22.5 mL) Bottle, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-34-01, UPC 8 10096 77170 4.

Reason for recall

CGMP Deviations

Distribution pattern

DE and NC

Code information

Lot SP31A, Exp Date: 09/30/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0422-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0422-2025. Report a data issue: hello@regdatalab.com.